Evaluation of the relationship between migraine disorder andoral comorbidities: multicenter randomized clinical trial

Evaluation of the relationship between migraine disorder andoral comorbidities: multicenter randomized clinical trial

Background/aim: Although migraine is a common disorder, there is a lack of research investigating the possible relationship between migraine and oral health. The aim of the present study was to explore the relationship between temporomandibular disorders, bruxism, dental caries, periodontal status, and migraine disorder in a multicenter, parallel, case-controlled clinical study. Materials and methods: A total of 2001 participants were divided into two groups: migraineurs (nm = 998) and nonmigraineurs (nh = 1003). International Headache Society s Second Edition of International Classification of Headache Disorders and modified Migraine Disability Assessment surveys were administered to evaluate the level of migraine; a pretreatment questionnaire and the World Health Organization oral health assessment form were used to determine the oral comorbidities and their possible effects on DMFT index, gingival plaque index, existence of temporomandibular disorders, bruxism, and consistency of daily oral hygiene habits. Results: The mean age was 39.6 ± 10.5 years. Female patients seemed to experience migraine attacks more than male patients (64%). The frequency of gastroesophageal reflux was higher in migraineurs in comparison with nonmigraineurs (47%) and tooth wear and abrasion also seemed more frequent (76%). DMFT and plaque index scores showed significant differences for both groups. Conclusion: There is a strong relationship between migraine and oral health status. The existence of reflux in addition to migraine leads to higher dental problems.

___

  • 1. Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol 2010; 30: 107-119.
  • 2. Zarifoglu M, Siva A, Hayran O. An epidemiological study of headache in Turkey: a nationwide survey. Neurology 1998; 50: 80-85.
  • 3. Pinto A, Parastatidis MA, Balasubramaniam R. Headache in children and adolescents. J Can Dent Assoc 2009; 75: 1488- 1519.
  • 4. Schürks M, Rist PM, Bigal ME. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 27: 339-347.
  • 5. Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia 2009; 29: 987-996.
  • 6. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005; 18: 305-10-17.
  • 7. Wang SJ, Chen PK. Comorbidities of migraine. Front Neurol 2010; 1: 16-21.
  • 8. Melis M, Secci S. Migraine with aura and dental occlusion. J Mass Dent Soc 2006; 54: 28-30.
  • 9. Guaré RO, Ferreira MC. Dental erosion and salivary flow rate in cerebral palsy individuals with gastroesophageal reflux. J Oral Pathol Med 2011; 10: 1111-1120.
  • 10. Ranjitkar S, Kaidonis JA, Smales RJ. Gastroesophageal reflux disease and tooth erosion. Int J Dent 2012; 85: 1-10.
  • 11. Bartlett DW, Shah P. A critical review of non-carious cervical (wear) lesions and the role of abfraction, erosion, and abrasion. J Dent Res 2006; 85: 306-312.
  • 12. Stich H. Erosion. Clinical aspects--diagnosis--risk factors-- prevention--therapy. Schweiz Monatsschr Zahnmed 2005; 115: 917-946 (article in French with an abstract in English).
  • 13. Park JW, Cho YS, Lee SY. Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients. Gut Liver 2013; 7: 668-674.
  • 14. Meucci G, Radaelli F, Prada A. Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open-access upper gastrointestinal endoscopy. Endoscopy 2005; 37: 622-627.
  • 15. Chorążka K, Janoska M, Domitrz I. Body mass index and its impact on migraine prevalence and severity in female patients: preliminary results. Neurol Neurochir Pol 2014; 48: 163-166.
  • 16. Moskowitz MA. Pathophysiology of headache--past and present. Headache 2007; 47: S58-S63.
  • 17. Teixeira AL Jr, Meira FC, Maia DP. Migraine headache in patients with Sydenham’s chorea. Cephalalgia 2005; 25: 542- 544.
  • 18. Goncalves DA, Camparis CM, Speciali JG. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study. J Orofac Pain 2013; 27: 325-335.
  • 19. Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: evidence for diagnostic and behavioral overlap. Cephalalgia 2007; 27: 542-549.
  • 20. Gesch D, Bernhardt O, Alte D. Prevalence of signs and symptoms of temporomandibular disorders in a urban and rural German population: results of a population-based study of health in Pomerania. Quintessence Int 2004; 35: 143-150.
  • 21. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ 2006; 7: 25-29.
  • 22. Valade D. Chronic migraine. Rev Neurol 2013; 169: 419-426.
  • 23. Lainez MJ, Castillo J, Dominguez M. New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care. BMC Neurol 2010; 10: 39-46.
  • 24. Liu J, Qin W. Gender-related differences in the dysfunctional resting networks of migraine suffers. Plos One 2011; 6: 10.1371-1378.
  • 25. Bope ET, Kellerman RD. Conn’s Current Therapy: 2015. 1st ed. Philadelphia, PA, USA: Elsevier Health Sciences Publishing, 2014.
  • 26. Jürgens TP, Schulte LH, May A. Migraine trait symptoms in migraine with and without aura. Neurology 2014; 82: 1416- 1424.
  • 27. Sacco S, Ricci S. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia 2012; 32: 785-795.
  • 28. Ylöstalo PV, Järvelin MR, Laitinen J. Gingivitis, dental caries and tooth loss: risk factors for cardiovascular diseases or indicators of elevated health risks. J Clin Periodontol 2006; 33: 92-101.
  • 29. Shoji Y. Cluster headache following dental treatment: a case report. Journal of Oral Science 2011; 53: 125-127.
  • 30. Tjensvoll AB, Gøransson LG, Harboe E,  Kvaløy JT,  Omdal R. High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren’s syndrome. Eur J Neurol 2014; 21: 1124-1130.
  • 31. Rezai A, Ansarinia M. Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system. US Patent Application 2005; 11/222,766.
  • 32. Gupta R, Bhatia MS. Comparison of clinical characteristics of migraine and tension type headache. Indian Journal of Psychiatry 2011; 53: 134-140.
  • 33. Machado NAG, Fonseca RB. Dental wear caused by association between bruxism and gastroesophageal reflux: a rehabilitation report. J Appl Oral Sci 2007; 15: 327-336.
  • 34. Wan Nik WNN, Banerjee A, Moazzez R. Gastro-oesophageal reflux disease symptoms and tooth wear in patients with Sjögren’s syndrome. Caries Res 2011; 45: 323-326.
  • 35. Blumenfeld A, Bender SD, Glassman B. Bruxism, temporomandibular dysfunction, tension type headache, and migraine: a comment. Headache 2011; 51: 1549-1558.
  • 36. Silva AA Jr, Brandão KV, Faleiros BE. Temporo-mandibular disorders are an important comorbidity of migraine and may be clinically difficult to distinguish them from tension-type headache. Arq Neuro-psiquiat 2014; 72: 99-103.
  • 37. Takeuchi M, Kato M, J Saruta J. Relationship between migraine and malocclusion. J Headache Pain 2013; 14: 136-138.
  • 38. Steele JG, Lamey PJ, Sharkey SW. Occlusal abnormalities, pericranial muscle and joint tenderness and tooth wear in a group of migraine patients. J Oral Rehabil 1991; 18: 453-458.
  • 39. Pistoia F, Sacco S, Carolei A. Behavioral therapy for chronic migraine. Curr Pain Headache R 2013; 17: 304-309.
  • 40. Hugo FN, Hilgert JB, de Sousa ML. Oral status and its association with general quality of life in older independentliving south-Brazilians. Community Dent Oral 2009; 37: 231- 240.
  • 41. Matharu MS, van Vliet JA, Ferrari MD. Verapamil induced gingival enlargement in cluster headache. JNNP 2005; 76: 124- 129.
  • 42. Jeske AH. Migraine drug therapy: dental implications. Texas Dental Journal 2006; 123: 190-197.
  • 43. McDonald SA, Hershey AD. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 2011; 51: 1374-1379.
  • 44. Nixdorf DR, Velly AM, Alonso AA. Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon. Oral Maxillofac Surg Clin Nor Am 2008; 20: 221-235.